GLP-1 products have driven outsized market value growth: Since the launch of their first GLP-1 products, Novo Nordisk and Eli Lilly have experienced a combined $697 billion increase in market capitalization or total company value, which is 10 times greater than the $71 billion in U.S
The result is a steady, sustainable increase in endogenous GH and IGF-1, the systemic signals that influence overall regenerative capacity including hair follicle health
According to Cancer Research UK, hyperinsulinaemia and insulin resistance have been linked to increased breast cancer risk and potentially recurrence, suggesting that medicines improving these metabolic parameters could hypothetically offer indirect benefits
It is naturally present in the body but can be depleted by stress, poor diet, toxins, and more
For more information, see this article on exercise and immunity